Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

2011

4001 ARTíCULOS , VIENDO DEL 1 AL 15

PUBMED

Lack of association of LINGO1 rs9652490 and rs11856808 SNPs with familial essential tremor.

Lorenzo-Betancor O, García-Martín E, Cervantes S, Agúndez JA, Jiménez-Jiménez FJ, Alonso-Navarro H, Luengo A, Coria F, Lorenzo E, Irigoyen J, Pastor P.

Eur J Neurol. 2011 Aug;18(8):1085-9. doi: 10.1111/j.1468-1331.2010.03251.x.

0

0

0

PUBMED

Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington's disease and depression.

Renoir T, Zajac MS, Du X, Pang TY, Leang L, Chevarin C, Lanfumey L, Hannan AJ.

PLoS One. 2011;6(7):e22133. doi: 10.1371/journal.pone.0022133.

0

0

0

PUBMED

Functional electrical stimulation of dorsiflexor muscle: effects on dorsiflexor strength, plantarflexor spasticity, and motor recovery in stroke patients.

Sabut SK, Sikdar C, Kumar R, Mahadevappa M.

NeuroRehabilitation. 2011;29(4):393-400. doi: 10.3233/NRE-2011-0717.

0

0

0

PUBMED

Head tremor related to CACNA1A mutations.

Geerlings RP, Koehler PJ, Haane DY, Stam AH, de Vries B, Boon EM, Haan J.

Cephalalgia. 2011 Sep;31(12):1315-9. doi: 10.1177/0333102411414442.

0

0

0

PUBMED

Dysregulation of upstream binding factor-1 acetylation at K352 is linked to impaired ribosomal DNA transcription in Huntington's disease.

Lee J, Hwang YJ, Boo JH, Han D, Kwon OK, Todorova K, Kowall NW, Kim Y, Ryu H.

Cell Death Differ. 2011 Nov;18(11):1726-35. doi: 10.1038/cdd.2011.38.

0

0

0

PUBMED

New non-oral drug delivery systems for Parkinson's disease treatment.

Md S, Haque S, Sahni JK, Baboota S, Ali J.

Expert Opin Drug Deliv. 2011 Mar;8(3):359-74. doi: 10.1517/17425247.2011.556616. Review.

0

0

0

PUBMED

Strength and activation of the knee musculature in Parkinson's disease: effect of medication.

Folland JP, Haas B, Castle PC.

NeuroRehabilitation. 2011;29(4):405-11. doi: 10.3233/NRE-2011-0719.

0

0

0

PUBMED

[The pathomechanisms of young-onset Parkinson's disease (PD), approach to the causes of PD form the mechanisms of insulin secretion system].

Hattori N, Eguchi H, Imaizumi M, Saiki S, Sato S, Nagamatsu S.

Rinsho Shinkeigaku. 2011 Nov;51(11):986-7. Japanese. No abstract available.

0

0

0

PUBMED

Acute effects of bilateral subthalamic stimulation on decision-making in Parkinson's disease.

Oyama G, Shimo Y, Natori S, Nakajima M, Ishii H, Arai H, Hattori N.

Parkinsonism Relat Disord. 2011 Mar;17(3):189-93. doi: 10.1016/j.parkreldis.2010.12.004.

0

0

0

PUBMED

[Nonsteroidal analgesics have a protective effect against Parkinson disease].

Steurer J.

Praxis (Bern 1994). 2011 May 11;100(10):617-8. doi: 10.1024/1661-8157/a000535. German. No abstract available.

0

0

0

PUBMED

Meclizine is neuroprotective in models of Huntington's disease.

Gohil VM, Offner N, Walker JA, Sheth SA, Fossale E, Gusella JF, MacDonald ME, Neri C, Mootha VK.

Hum Mol Genet. 2011 Jan 15;20(2):294-300. doi: 10.1093/hmg/ddq464.

0

0

0

PUBMED

Body composition in premanifest Huntington's disease reveals lower bone density compared to controls.

Goodman AO, Barker RA.

Version 2. PLoS Curr. 2011 Feb 28 [revised 2011 Jan 1];3:RRN1214.

0

0

0

PUBMED

Morvan chorea and agrypnia excitata: when video-polysomnographic recording guides the diagnosis.

Provini F, Marconi S, Amadori M, Guaraldi P, Pierangeli G, Cortelli P, Lugaresi E, Montagna P, Tinuper P.

Sleep Med. 2011 Dec;12(10):1041-3. doi: 10.1016/j.sleep.2011.05.005.

0

0

0

PUBMED

Blood cells from Friedreich ataxia patients harbor frataxin deficiency without a loss of mitochondrial function.

Selak MA, Lyver E, Micklow E, Deutsch EC, Onder O, Selamoglu N, Yager C, Knight S, Carroll M, Daldal F, Dancis A, Lynch DR, Sarry JE.

Mitochondrion. 2011 Mar;11(2):342-50. doi: 10.1016/j.mito.2010.12.003.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy